Phenotypic Pharmaceuticals LLC is categorized under Commercial Medical Research in San Diego, CA and active since 2009.
Phenotypic Pharmaceuticals LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Lance Smith at the company’s single location by writing to 8717 Creekwood Lane, San Diego, California CA 92129 or by phoning (858) 837-0108. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Phenotypic Pharmaceuticals LLC |
| Contact Person: | Lance Smith |
| Address: | 8717 Creekwood Lane, San Diego, California 92129 |
| Phone Number: | (858) 837-0108 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Phenotypic Pharmaceuticals LLC was started in 2009 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Lance Smith for inquiries that concern Phenotypic Pharmaceuticals LLC by calling the company number (858) 837-0108, as your correspondence is most welcome. Additionally, the physical location of the single location of Phenotypic Pharmaceuticals LLC can be found at the coordinates as well as the street address 8717 Creekwood Lane in San Diego, California 92129.
For its online presence, you may visit Phenotypic Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.